| Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
|---|
| 02/21/2002 | US20020022623 A substituted hydroxyethylene compound useful for treating Alzheimer's disease, mild cognitive impairment, Down's syndrome, herediatary cerebral hemmorrhage with amyloidosis, degenerative dementia |
| 02/21/2002 | US20020022023 Treatment of diabetes mellitus and insulin receptor signal transduction |
| 02/19/2002 | US6348614 Aminobutyric acid fungicides |
| 02/19/2002 | US6348593 Process for preparing folic acid |
| 02/19/2002 | US6348499 Amphiphilic polyamide compounds |
| 02/19/2002 | US6348207 Exposing biologically active agent to complexing perturbant to reversibly transform biologically active agent to intermediate state and form orally deliverable supramolecular complex, orally administering complex to subject |
| 02/19/2002 | CA2017217C Amino acid derivative anticonvulsant |
| 02/14/2002 | WO2002012210A1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 02/14/2002 | WO2002012170A1 8-substituted tetracycline compounds |
| 02/14/2002 | WO2002011714A2 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 02/14/2002 | WO2001070671A3 Insecticidal anthranilamides |
| 02/14/2002 | WO2001062711A3 Substituted alkylene diamine compounds |
| 02/14/2002 | WO2001042173A3 Method for the preparation of enantiomerically enriched compounds |
| 02/14/2002 | US20020019538 Prevention binding of transcription factor tozinc finger binding compounds |
| 02/14/2002 | US20020019416 Esters and amides as pla2 inhibitors |
| 02/14/2002 | US20020019414 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/14/2002 | US20020019412 Antidiabetic agents |
| 02/14/2002 | US20020019403 Inhibit amyloid protein deposits |
| 02/14/2002 | US20020019013 Combined resin method for high-speed synthesis of combinatorial libraries |
| 02/14/2002 | DE10038007A1 Neue Amino-und Amido-Diphenylether für Arzneimittel New amino and amido diphenyl ether for drugs |
| 02/14/2002 | CA2418951A1 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 02/14/2002 | CA2418895A1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 02/13/2002 | EP1178954A1 A structure-based approach to design inhibitors of protein-processivity factor interactions |
| 02/12/2002 | US6346242 Compounds and compositions for delivering active agents |
| 02/07/2002 | WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | WO2002010121A1 Amides from hydrocarbyl amines and the use thereof |
| 02/07/2002 | WO2002009648A2 Antimicrobial biaryl compounds |
| 02/07/2002 | WO2001000566A3 Substituted phenoxyacetic acids |
| 02/07/2002 | US20020016464 Sodium channel blockers used to treat amyotrophic lateral sclerosis; analgesics, anticonvulsants, antidepressants, local anesthetics and antiarrhythmics |
| 02/07/2002 | US20020016461 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 02/07/2002 | US20020016355 Synthetic pathway relies upon stereospecific synthesis of oxazoline intermediate and stereoselective addition of formyl amide to oxazoline |
| 02/07/2002 | US20020016350 Useful in treatment of diseases or conditions associated with erythropoietin receptor |
| 02/07/2002 | DE10036956A1 Amide von Hydrocarbylaminen und Verwendung dieser Amide Amides of hydrocarbyl amines and amides using these |
| 02/07/2002 | CA2418121A1 Antimicrobial biaryl compounds |
| 02/07/2002 | CA2417638A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/06/2002 | EP1177168A1 Caspase inhibitors and the use thereof |
| 02/06/2002 | EP0729354B1 Farnesyl derivatives and pharmaceutical compositions containing them |
| 02/06/2002 | CN1078886C Inhibitor of inhibiting generation of beta-amyloid |
| 02/05/2002 | US6344558 Analgesics |
| 02/05/2002 | US6344213 Compounds and compositions for delivering active agents |
| 01/31/2002 | WO2002008247A2 Process for the preparation of 5-phenylpentanoyl-ala-argl-{2-[3-amino-2-oxopyrrolidin-1-yl]propionyl}-ala-arg-ala-4-aminophenylacetamide |
| 01/31/2002 | WO2002008213A1 Colchinol derivatives as angiogenesis inhibitors |
| 01/31/2002 | WO2002008189A1 Compounds and inhibitors of phospholipases |
| 01/31/2002 | WO2002008172A1 Process for the preparation of substituted octanoyl amides |
| 01/31/2002 | CA2417127A1 Compounds and inhibitors of phospholipases |
| 01/31/2002 | CA2412787A1 Process for the preparation of 5-phenylpentanoyl-ala-argl-{2-[3-amino-2-oxopyrrolidin-1-yl]propionyl}-ala-arg-ala-4-aminophenylacetamide |
| 01/31/2002 | CA2410562A1 Colchinol derivatives as angiogenesis inhibitors |
| 01/30/2002 | EP1175392A1 Contrast media |
| 01/30/2002 | CN1078586C Phenylalkanamide derivatives and agrohor-ticultural bactericides |
| 01/29/2002 | US6342629 Process for production of optically active n-protected-n-methyl-phenylalanine derivative |
| 01/29/2002 | US6342624 Use of propargyl glycine amino propargyl diol compounds for inhibiting plasma renin activity |
| 01/29/2002 | US6342598 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents |
| 01/29/2002 | US6342524 Use of non-steroidal anti-inflammatory agents in combination with compounds that have FP prostaglandin agonist activity to treat glaucoma and ocular hypertension |
| 01/24/2002 | US20020010368 Preparation of iodixanol |
| 01/24/2002 | US20020010178 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effect |
| 01/24/2002 | DE10033518A1 Process for the separation of ammonia from 2-phase reaction mixture obtained in amide preparation, involves separating phases and extracting organic phase with aqueous medium |
| 01/23/2002 | EP1173413A1 Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors |
| 01/23/2002 | EP1173408A1 Ppar-(gamma) agonists as agents for the treatment of type ii diabetes |
| 01/23/2002 | EP0726771B1 Desferrioxamine oral delivery system |
| 01/23/2002 | CN1332722A 2-substituted Retoamides |
| 01/23/2002 | CN1078201C Prep of contrast medium 'Dianhaichun' |
| 01/17/2002 | WO2002004412A2 Tyrosine derivatives as phosphatase inhibitors |
| 01/17/2002 | WO2002004407A2 7-substituted tetracycline compounds |
| 01/17/2002 | WO2002004406A2 9-substituted minocycline compounds |
| 01/17/2002 | WO2002004405A2 13-substituted methacycline compounds |
| 01/17/2002 | WO2002004404A2 7,8 and 9-substituted tetracycline compounds |
| 01/17/2002 | WO2002003995A2 Treatment of male sexual dysfunction |
| 01/17/2002 | WO2001062726A3 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 01/17/2002 | WO2001055107A3 Aromatic amines and amides acting on the melanocortin receptors |
| 01/17/2002 | WO2001046125A3 Cd45 inhibitors |
| 01/17/2002 | WO2001040148A3 Systems and methods to facilitate multiple order combinatorial chemical processes |
| 01/17/2002 | US20020007073 Capable of producing complexes with polynucleotides (DNA, RNA, antisense oligonucleotides, ribozymes); suitable as vectors for transfection |
| 01/17/2002 | US20020006958 Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof |
| 01/17/2002 | US20020006957 Method for the synthesis of compounds of formula I and their uses thereof |
| 01/17/2002 | US20020006898 Trimethyl lock based tetrapartate prodrugs |
| 01/17/2002 | DE10033337A1 Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel Biphenylcarbonsäureamide, their preparation and their use as medicaments |
| 01/17/2002 | CA2415172A1 13-substituted methacycline compounds |
| 01/17/2002 | CA2415086A1 7,8 and 9-substituted tetracycline compounds |
| 01/17/2002 | CA2414112A1 Treatment of male sexual dysfunction |
| 01/16/2002 | EP1172354A2 Process for the preparation of (schiff bases of)alpha-alkyl-alpha-amino acid amides |
| 01/16/2002 | EP1171432A1 Adamantane derivatives |
| 01/16/2002 | EP0912586B1 Functionalized ferrocenyldiphosphines, a process for their preparation and their use |
| 01/16/2002 | EP0912508B1 Process for preparing caprolactam from 6-aminocapronitrile |
| 01/16/2002 | CN1331682A Substituted 2-phenylbenzimidazoles, prodn. thereof and their use |
| 01/16/2002 | CN1331680A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors |
| 01/15/2002 | US6339173 For interfering with protein expression in a cell; useful in lipid aggregates for the delivery of macromolecules into cells |
| 01/10/2002 | WO2002002546A1 EPOXYCARBOXYLIC ACID AMIDES, AZIDES AND AMINO ALCOHOLS AND PROCESSES FOR PREPARATION OF α-KETO AMIDES BY USING THEM |
| 01/10/2002 | WO2002002538A1 Amino acid-n-carboxy anhydrides hvaing substituent at nitrogen |
| 01/10/2002 | WO2002002513A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | WO2002002512A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002511A1 Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness |
| 01/10/2002 | WO2002002508A1 Process for the preparation of substituted octanoyl amides |
| 01/10/2002 | US20020004522 Nervous system disorders |
| 01/10/2002 | CA2414881A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | CA2410651A1 Compounds to treat alzheimer's disease |
| 01/09/2002 | EP1169301A1 A topical antiandrogen for hair loss and other hyperandrogenic conditions |
| 01/09/2002 | EP1169294A2 Pharmaceutical compounds |
| 01/09/2002 | EP1169038A1 Cyclic protein tyrosine kinase inhibitors |
| 01/09/2002 | CN1330631A Amide derivatives which are useful as cell factor inhibitors |
| 01/09/2002 | CN1330628A Crosslinkers based on dibenzalacetone derivatives |